Armistice Capital, LLC 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 1,313,348 9.990% |
234,889 (+21.78%) |
Filing |
| 2024-02-14 2:23 pm Purchase |
2023-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 1,078,459 9.990% |
122,464 (+12.81%) |
Filing |
| 2023-02-14 12:06 pm Purchase |
2022-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 955,995 9.990% |
23,943 (+2.57%) |
Filing |
| 2022-02-14 6:31 pm Purchase |
2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 932,052 9.990% |
491,308 (+111.47%) |
Filing |
| 2021-02-16 5:10 pm Sale |
2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 440,744 8.000% |
-1,309,256 (-74.81%) |
Filing |